ArticleMolecular therapy oncolytics2022

Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer.

Coby Rangsitratkul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.